RSCF - Reflect Scientific, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
1,410
1,552
1,066
1,189
Cost of Revenue
407
487
406
376
Gross Profit
1,003
1,065
660
813
Operating Expenses
Research Development
160
104
47
71
Selling General and Administrative
952
1,210
1,015
993
Total Operating Expenses
1,112
1,314
1,062
1,064
Operating Income or Loss
-109
-249
-402
-252
Interest Expense
-
1
0
0
Total Other Income/Expenses Net
-
-
-
36
Income Before Tax
-110
-250
-402
-216
Income Tax Expense
0
0
0
0
Income from Continuing Operations
-110
-250
-402
-216
Net Income
-110
-250
-402
-216
Net Income available to common shareholders
-110
-250
-402
-216
Reported EPS
Basic
-
-0.00
-0.01
-0.00
Diluted
-
-0.00
-0.01
-0.00
Weighted average shares outstanding
Basic
-
74,631
66,326
62,964
Diluted
-
74,631
66,326
62,964
EBITDA
-
-246
-402
-211